{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:16:51Z","timestamp":1775002611479,"version":"3.50.1"},"publisher-location":"Cham","reference-count":69,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032041524","type":"print"},{"value":"9783032041531","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-04153-1_32","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:20:48Z","timestamp":1774999248000},"page":"565-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycan Remodeling Technologies for Enhancing Antibody Function"],"prefix":"10.1007","author":[{"given":"Shino","family":"Manabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Methanee","family":"Hiranyakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"32_CR1","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1039\/C7OB01027C","volume":"15","author":"Y Anami","year":"2017","unstructured":"Anami Y et al (2017) Enzymatic conjugation using branched linkers for constructing homogeneous antibody\u2013drug conjugates with high potency. Org Biomol Chem 15:5635\u20135642. https:\/\/doi.org\/10.1039\/C7OB01027C","journal-title":"Org Biomol Chem"},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/19420862.2019.1608143","volume":"5","author":"M Aoyama","year":"2019","unstructured":"Aoyama M (2019) Effects of terminal galactose residues in mannose \u03b11-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies. MAbs 5:826\u2013836. https:\/\/doi.org\/10.1080\/19420862.2019.1608143","journal-title":"MAbs"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"16101","DOI":"10.1073\/pnas.1211023109","volume":"109","author":"JY Axup","year":"2012","unstructured":"Axup JY et al (2012) Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc Natl Acad Sci USA 109:16101\u201316106. https:\/\/doi.org\/10.1073\/pnas.1211023109","journal-title":"Proc Natl Acad Sci USA"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nchembio.511","volume":"7","author":"AW Barb","year":"2011","unstructured":"Barb AW, Prestegard JH (2011) NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat Chem Biol 7:147\u2013153. https:\/\/doi.org\/10.1038\/nchembio.511","journal-title":"Nat Chem Biol"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd.2017.227","volume":"17","author":"PJ Carter","year":"2018","unstructured":"Carter PJ, Lazar GA (2018) Next generation antibody drugs: pursuit of the \u2018high-hanging fruit\u2019. Nat Rev Drug Discov 17:197\u2013223. https:\/\/doi.org\/10.1038\/nrd.2017.227","journal-title":"Nat Rev Drug Discov"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1021\/acschembio.7b00140","volume":"12","author":"CL Chen","year":"2017","unstructured":"Chen CL et al (2017) Crystal structure of a homogeneous IgG-Fc Glycoform with the N-glycan designed to maximize the antibody dependent cellular cytotoxicity. ACS Chem Biol 12:1335\u20131345. https:\/\/doi.org\/10.1021\/acschembio.7b00140","journal-title":"ACS Chem Biol"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/bit.1119","volume":"74","author":"J Davis","year":"2001","unstructured":"Davis J et al (2001) Expression of GnT-III in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered Glycoforms leads to an increase in ADCC through higher affinity for Fc\u03b3RIII. Biotechnol Bioeng 74:288\u2013294. https:\/\/doi.org\/10.1002\/bit.1119","journal-title":"Biotechnol Bioeng"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","volume":"8","author":"G Dekkers","year":"2017","unstructured":"Dekkers G (2017) Decoding the human immunoglobulin G-glycan repertoire reveals a Spectrum of Fc-receptor- and complement-mediated-effector activities. Front Immunol 8:877. https:\/\/doi.org\/10.3389\/fimmu.2017.00877","journal-title":"Front Immunol"},{"key":"32_CR9","doi-asserted-by":"publisher","unstructured":"Dong W, Wang W, Cao C (2024) The evolution of antibody-drug conjugates: toward accurate DAR and multi-specificity. ChemMedChem e202400109. https:\/\/doi.org\/10.1002\/cmdc.202400109","DOI":"10.1002\/cmdc.202400109"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","volume":"22","author":"C Dumontet","year":"2023","unstructured":"Dumontet C et al (2023) Antibody-drug conjugates come of age in oncology. Nat Rev Drug Discov 22:641\u2013661. https:\/\/doi.org\/10.1038\/s41573-023-00709-2","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"32_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132859","volume":"10","author":"Y Eshima","year":"2015","unstructured":"Eshima Y et al (2015) Transglycosylation activity of Glycosynthase mutants of Endo-\u03b2-N-Acetylglucosaminidase from Coprinopsis cinerea. PLoS One 10(7):e0132859. https:\/\/doi.org\/10.1371\/journal.pone.0132859","journal-title":"PLoS One"},{"key":"32_CR12","doi-asserted-by":"publisher","first-page":"11272","DOI":"10.1074\/jbc.M112.340497","volume":"287","author":"SQ Fan","year":"2012","unstructured":"Fan SQ et al (2012) Remarkable Transglycosylation activity of Glycosynthase Mutants of Endo-D, an Endo-\u03b2-N-acetylglucosaminidase from Streptococcus pneumoniae. J Biol Chem 287:11272\u201311281. https:\/\/doi.org\/10.1074\/jbc.M112.340497","journal-title":"J Biol Chem"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/bit.20777","volume":"93","author":"C Ferrara","year":"2006","unstructured":"Ferrara C et al (2006) Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous \u03b21,4-N-acetylglucosaminyltransferase III and Golgi \u03b1-mannosidase III. Biotechnol Bioeng 93:851\u2013886. https:\/\/doi.org\/10.1002\/bit.20777","journal-title":"Biotechnol Bioeng"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/acs.bioconjchem.3c00040","volume":"34","author":"T Fujii","year":"2023","unstructured":"Fujii T et al (2023) AJICAP second generation: improved chemical site-specific conjugation technology for antibody-drug conjugate production. Bioconjug Chem 34:728\u2013738. https:\/\/doi.org\/10.1021\/acs.bioconjchem.3c00040","journal-title":"Bioconjug Chem"},{"key":"32_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.abb.2004.09.013","volume":"432","author":"K Fujita","year":"2004","unstructured":"Fujita K et al (2004) Molecular cloning of Mucor hiemalis endo-\u03b2-N-acetylglucosaminidase and some properties of the recombinant enzyme. Arc Biochem Biophys 432:41\u201349. https:\/\/doi.org\/10.1016\/j.abb.2004.09.013","journal-title":"Arc Biochem Biophys"},{"key":"32_CR16","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1074\/jbc.M116.721597","volume":"291","author":"JP Giddens","year":"2016","unstructured":"Giddens JP et al (2016) Endo-F3 Glycosynthase mutants enable Chemoenzymatic synthesis of Core-fucosylated Triantennary complex type Glycopeptides and glycoproteins. J Biol Chem 291:9356\u20139370. https:\/\/doi.org\/10.1074\/jbc.M116.721597","journal-title":"J Biol Chem"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.bmc.2018.03.011","volume":"26","author":"K Haneda","year":"2018","unstructured":"Haneda K et al (2018) Development of a microbioreactor for glycoconjugate synthesis. Bioorg Med Chem 26:2092\u20132098. https:\/\/doi.org\/10.1016\/j.bmc.2018.03.011","journal-title":"Bioorg Med Chem"},{"key":"32_CR18","doi-asserted-by":"publisher","unstructured":"Hiranyakorn M et al (2023) Chromatographic analysis of N-glycan profile on therapeutic antibodies using Fc\u03b3RIIIa affinity column chromatography. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.3c02374","DOI":"10.1021\/acsomega.3c02374"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1021\/jacsau.4c00004","volume":"4","author":"YC Hsieh","year":"2024","unstructured":"Hsieh YC et al (2024) Structure-based high-efficiency homogeneous antibody platform by endoglycosidase Sz provides insights into its transglycosylation mechanism. JACS Au 4:2130\u20132150. https:\/\/doi.org\/10.1021\/jacsau.4c00004","journal-title":"JACS Au"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"11272","DOI":"10.1021\/ja3051266","volume":"287","author":"W Huang","year":"2012","unstructured":"Huang W et al (2012) Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions. J Biol Chem 287:11272\u201311281. https:\/\/doi.org\/10.1021\/ja3051266","journal-title":"J Biol Chem"},{"key":"32_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1472-6750-7-84","volume":"7","author":"H Imai-Nishiya","year":"2007","unstructured":"Imai-Nishiya H et al (2007) Double knockdown of alfa1,6-fucosyltranseferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC. BMC Biotechnol 7:84. https:\/\/doi.org\/10.1186\/1472-6750-7-84","journal-title":"BMC Biotechnol"},{"key":"32_CR22","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1021\/acs.bioconjchem.8b00427","volume":"29","author":"M Iwamoto","year":"2018","unstructured":"Iwamoto M et al (2018) Pharmacokinetic and Pharmacodynamic profiles of Glyco-modified atrial natriuretic peptide derivatives synthesized using chemo-enzymatic synthesis approaches. Bioconjug Chem 29:2829\u20132837. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00427","journal-title":"Bioconjug Chem"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/glycob\/cwf073","volume":"12","author":"T Kato","year":"2002","unstructured":"Kato T et al (2002) Identification of an endo-\u03b2-N-acetylglucosaminidase gene in Carnorhabodilis elegans and its expression in Escherichia coli. Glycobiology 12:581\u2013587. https:\/\/doi.org\/10.1093\/glycob\/cwf073","journal-title":"Glycobiology"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/19420862.2017.1305530","volume":"9","author":"S Kim","year":"2017","unstructured":"Kim S et al (2017) Drifts in ADCC-related quality attributes of Herceptin\u00ae: impact on development of a trastuzumab biosimilar. MAbs 9:704\u2013714. https:\/\/doi.org\/10.1080\/19420862.2017.1305530","journal-title":"MAbs"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41598-018-22199-8","volume":"8","author":"M Kiyoshi","year":"2018","unstructured":"Kiyoshi M et al (2018) Assessing the heterogeneity of the Fc-Glycan of a therapeutic antibody using an engineered Fc\u03b3Receptor IIIa-immobilized column. Sci Rep 8:3955. https:\/\/doi.org\/10.1038\/s41598-018-22199-8","journal-title":"Sci Rep"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0022-2836(02)01250-0","volume":"325","author":"S Krapp","year":"2003","unstructured":"Krapp S (2003) Structural analysis of human IgG-Fc Glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 325:979\u2013989. https:\/\/doi.org\/10.1016\/S0022-2836(02)01250-0","journal-title":"J Mol Biol"},{"key":"32_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/cb4009292","volume":"9","author":"K Lang","year":"2014","unstructured":"Lang K, Chin JW (2014) Bioorthogonal reactions for labeling proteins. ACS Chem Biol 9:16. https:\/\/doi.org\/10.1021\/cb4009292","journal-title":"ACS Chem Biol"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1002\/anie.201402606","volume":"126","author":"X Li","year":"2014","unstructured":"Li X, Fang T, Boons GJ (2014) Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted Azide-alkyne cycloadditions. Angew Chem Int Ed 126:7307\u20137310. https:\/\/doi.org\/10.1002\/anie.201402606","journal-title":"Angew Chem Int Ed"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"16508","DOI":"10.1074\/jbc.M116.738765","volume":"291","author":"T Li","year":"2016","unstructured":"Li T et al (2016) Glycosynthase mutants of endoglycosidase S2 show potent Transglycosylation activity and remarkably relaxed substrate specificity for antibody glycosylation remodeling. J Biol Chem 291:16508\u201316518. https:\/\/doi.org\/10.1074\/jbc.M116.738765","journal-title":"J Biol Chem"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.carres.2018.02.007","volume":"458-459","author":"T Li","year":"2018","unstructured":"Li T et al (2018) Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies. Carbohydr Res 458-459:77\u201384. https:\/\/doi.org\/10.1016\/j.carres.2018.02.007","journal-title":"Carbohydr Res"},{"key":"32_CR31","doi-asserted-by":"publisher","first-page":"7828","DOI":"10.1021\/jacs.1c03174","volume":"143","author":"C Li","year":"2021","unstructured":"Li C et al (2021) Site-selective Chemoenzymatic modification on the Core Fucose of an antibody enhances its Fc\u03b3 receptor affinity and ADCC activity. J Am Chem Soc 143:7828\u20137838. https:\/\/doi.org\/10.1021\/jacs.1c03174","journal-title":"J Am Chem Soc"},{"key":"32_CR32","doi-asserted-by":"publisher","first-page":"10611","DOI":"10.1073\/pnas.1513456112","volume":"112","author":"CW Lin","year":"2015","unstructured":"Lin CW (2015) A common glycan structure on immunoglobulin G for enhancement of effector functions. Proc Natl Acad Sci USA 112:10611\u201310616. https:\/\/doi.org\/10.1073\/pnas.1513456112","journal-title":"Proc Natl Acad Sci USA"},{"key":"32_CR33","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/jps.24444","volume":"6","author":"L Liu","year":"2015","unstructured":"Liu L (2015) Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and fc-fusion proteins. J Pharm Sci 6:1866\u20131884. https:\/\/doi.org\/10.1002\/jps.24444","journal-title":"J Pharm Sci"},{"key":"32_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-024-01963-7","volume":"23","author":"K Liu","year":"2024","unstructured":"Liu K et al (2024) A review of the clinical efficacy of FDA-approved antibody\u2013drug conjugates in human cancers. Mol Cancer 23:62. https:\/\/doi.org\/10.1186\/s12943-024-01963-7","journal-title":"Mol Cancer"},{"key":"32_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11095-023-03628-4","volume":"41","author":"S Luo","year":"2024","unstructured":"Luo S, Zhang B (2024) Benchmark glycan profile of therapeutic monoclonal antibodies produced by mammalian cell expression systems. Pharm Res 41:29\u201337. https:\/\/doi.org\/10.1007\/s11095-023-03628-4","journal-title":"Pharm Res"},{"key":"32_CR36","doi-asserted-by":"publisher","first-page":"171521","DOI":"10.1098\/rsos.171521","volume":"5","author":"S Manabe","year":"2018","unstructured":"Manabe S et al (2018) Acceptor range of endo-\u03b2-N-acetylglucosaminidase mutant endo-CC N180H: from monosaccharide to antibody. R Soc Open Sci 5:171521\u2013171521. https:\/\/doi.org\/10.1098\/rsos.171521","journal-title":"R Soc Open Sci"},{"key":"32_CR37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1021\/acs.bioconjchem.9b00132","volume":"30","author":"S Manabe","year":"2019","unstructured":"Manabe S et al (2019) Characterization of antibody products obtained through enzymatic and nonenzymatic glycosylation reactions with a glycan Oxazoline and preparation of a homogeneous antibody-drug conjugate via Fc N-glycan. Bioconjug Chem 30:1343\u20131355. https:\/\/doi.org\/10.1021\/acs.bioconjchem.9b00132","journal-title":"Bioconjug Chem"},{"key":"32_CR38","doi-asserted-by":"publisher","unstructured":"Manabe S et al (2024) Systematic preparation of a 66-IgG library with symmetric and asymmetric homogeneous Glycans and their functional evaluation. J Am Chem Soc. https:\/\/doi.org\/10.1021\/jacs.4c06558","DOI":"10.1021\/jacs.4c06558"},{"key":"32_CR39","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1021\/acs.molpharmaceut.1c00473","volume":"18","author":"Y Matsuda","year":"2021","unstructured":"Matsuda Y et al (2021) Chemical site-specific conjugation platform to improve the pharmacokinetics and therapeutic index of antibody-drug conjugates. Mol Pharm 18:4058\u20134066. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00473","journal-title":"Mol Pharm"},{"issue":"589","key":"32_CR40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/protein\/gzt022","volume":"26","author":"F Mimoto","year":"2013","unstructured":"Mimoto F et al (2013a) Engineered antibody Fc variant with selectivity enhanced Fc\u03b3RIIb binding over both Fc\u03b3RIIaR131 and Fc\u03b3IIaH131. Protein Eng Des Sel 26(589):598. https:\/\/doi.org\/10.1093\/protein\/gzt022","journal-title":"Protein Eng Des Sel"},{"key":"32_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/mabs.23452","volume":"5","author":"F Mimoto","year":"2013","unstructured":"Mimoto F et al (2013b) Novel asymmetrically engineered antibody Fc variant with superior Fc\u03b3R binding affinity and specificity compared with afucosylated Fc variant. MAbs 5:229\u2013236. https:\/\/doi.org\/10.4161\/mabs.23452","journal-title":"MAbs"},{"key":"32_CR42","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2443.2011.01552.x","volume":"16","author":"T Mizushima","year":"2011","unstructured":"Mizushima T et al (2011) Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells 16:1071\u20131080. https:\/\/doi.org\/10.1111\/j.1365-2443.2011.01552.x","journal-title":"Genes Cells"},{"key":"32_CR43","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/oxfordjournals.jbchem.a002938","volume":"129","author":"Muramatsu","year":"2001","unstructured":"Muramatsu et al (2001) Molecular cloning and expression of Endo-\u03b2-N-Acetylglucosaminidase D, which acts on the Core structure of complex type asparagine-linked oligosaccharides. J Biochem 129:923\u2013928. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a002938","journal-title":"J Biochem"},{"key":"32_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2024.109024","volume":"536","author":"H Muto","year":"2024","unstructured":"Muto H et al (2024) Rapid preparation of a glycan oxazoline and a homogeneously glycosylated antibody with an enzyme-immobilized monolithic column. Carbohydr Res 536:109024. https:\/\/doi.org\/10.1016\/j.carres.2024.109024","journal-title":"Carbohydr Res"},{"key":"32_CR45","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.1073\/pnas.0702936104","volume":"104","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn F et al (2007) Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 104:8433\u20138437. https:\/\/doi.org\/10.1073\/pnas.0702936104","journal-title":"Proc Natl Acad Sci USA"},{"key":"32_CR46","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/hlca.201200414","volume":"95","author":"M Noguchi","year":"2012","unstructured":"Noguchi M et al (2012) A practical one-step synthesis of 1,2-Oxazoline derivatives from unprotected sugars and its application to Chemoenzymatic \u03b2-N-Acetylglucosaminidation of Disialo-oligosaccharide. Helv Chim Acta 95:1928\u20131936. https:\/\/doi.org\/10.1002\/hlca.201200414","journal-title":"Helv Chim Acta"},{"key":"32_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/rcm.3330","volume":"22","author":"P Olivova","year":"2008","unstructured":"Olivova P et al (2008) Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 22:29\u201340. https:\/\/doi.org\/10.1002\/rcm.3330","journal-title":"Rapid Commun Mass Spectrom"},{"key":"32_CR48","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1002\/anie.201402613","volume":"54","author":"BM Paterson","year":"2014","unstructured":"Paterson BM et al (2014) Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: Sortase-mediated coupling of Copper-64 to a single-chain antibody. Angew Chem Int Ed 54:6115\u20136119. https:\/\/doi.org\/10.1002\/anie.201402613","journal-title":"Angew Chem Int Ed"},{"key":"32_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","volume":"8","author":"B Peschke","year":"2017","unstructured":"Peschke B et al (2017) Fc-Galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity. Front Immunol 8:646. https:\/\/doi.org\/10.3389\/fimmu.2017.00646","journal-title":"Front Immunol"},{"key":"32_CR50","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.coi.2008.06.007","volume":"20","author":"TS Raju","year":"2008","unstructured":"Raju TS (2008) Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol 20:471\u2013478. https:\/\/doi.org\/10.1016\/j.coi.2008.06.007","journal-title":"Curr Opin Immunol"},{"key":"32_CR51","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.molimm.2006.09.005","volume":"44","author":"BJ Scallon","year":"2007","unstructured":"Scallon BJ (2007) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524\u20131534. https:\/\/doi.org\/10.1016\/j.molimm.2006.09.005","journal-title":"Mol Immunol"},{"key":"32_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s42004-024-01297-x","volume":"7","author":"I Senini","year":"2024","unstructured":"Senini I (2024) Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments. Commun Chem 7:203. https:\/\/doi.org\/10.1038\/s42004-024-01297-x","journal-title":"Commun Chem"},{"key":"32_CR53","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/acs.jmedchem.2c01812","volume":"66","author":"W Shi","year":"2022","unstructured":"Shi W et al (2022) Hiding payload inside the IgG fc cavity significantly enhances the therapeutic index of antibody\u2212drug conjugates. J Med Chem 66:1011\u20131026. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01812","journal-title":"J Med Chem"},{"key":"32_CR54","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","volume":"278","author":"T Shinkawa","year":"2003","unstructured":"Shinkawa T et al (2003) The absence of Fucose but not the presence of galactose or bisecting N-Acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466\u20133473. https:\/\/doi.org\/10.1074\/jbc.M210665200","journal-title":"J Biol Chem"},{"key":"32_CR55","doi-asserted-by":"publisher","unstructured":"Shivatare VS et al (2023) Probing the internalization and efficacy of antibody-drug conjugate via site-specific fc-glycan labelling of a homogeneous antibody targeting SSEA-4 bearing tumors. Isr J Chem:e202300042. https:\/\/doi.org\/10.1002\/ijch.202300042","DOI":"10.1002\/ijch.202300042"},{"key":"32_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/35018508","volume":"406","author":"P Sondermann","year":"2000","unstructured":"Sondermann P et al (2000) The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc\u03b3RIII complex. Nature 406:267\u2013273. https:\/\/doi.org\/10.1038\/35018508","journal-title":"Nature"},{"key":"32_CR57","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1074\/jbc.270.7.3094","volume":"270","author":"K Takegawa","year":"1995","unstructured":"Takegawa K et al (1995) Synthesis of Neoglycoproteins using oligosaccharide-transfer activity with Endo-\u03b2-N-Acetylglucosaminidase. J Biol Chem 270:3094\u20133099. https:\/\/doi.org\/10.1074\/jbc.270.7.3094","journal-title":"J Biol Chem"},{"key":"32_CR58","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1006\/abbi.1996.9803","volume":"263","author":"K Takegawa","year":"1997","unstructured":"Takegawa K et al (1997) Cloning, sequencing, and expression of Arthrobacter protophormiae Endo-\u03b2-N-acetylglucosaminidase in Escherichia coli. Arch Biochem Biophys 263:3657\u20133663. https:\/\/doi.org\/10.1006\/abbi.1996.9803","journal-title":"Arch Biochem Biophys"},{"key":"32_CR59","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1158\/1535-7163.MCT-22-0786","volume":"22","author":"D Toader","year":"2023","unstructured":"Toader D et al (2023) Discovery and preclinical characterization of XMT-1660, an optimized B7-H4-targeted antibody\u2013drug conjugate for the treatment of cancer. Mol Cancer Ther 22:999\u20131012. https:\/\/doi.org\/10.1158\/1535-7163.MCT-22-0786","journal-title":"Mol Cancer Ther"},{"key":"32_CR60","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/s41467-018-04300-x","volume":"9","author":"B Trastoy","year":"2018","unstructured":"Trastoy B et al (2018) Structural basis for the recognition of complex-type N-glycans by endoglycosidase S. Nat Commun 9:1874. https:\/\/doi.org\/10.1038\/s41467-018-04300-x","journal-title":"Nat Commun"},{"key":"32_CR61","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/19420862.2018.1551044","volume":"11","author":"R Wada","year":"2019","unstructured":"Wada R et al (2019) Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoslonal antibody with homogeneous glycoforms. MAbs 11:351\u2013372. https:\/\/doi.org\/10.1080\/19420862.2018.1551044","journal-title":"MAbs"},{"key":"32_CR62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/19420862.2018.1546086","volume":"11","author":"S Yageta","year":"2019","unstructured":"Yageta S, Imamura H, Shibuya R, Honda S (2019) CH2 domain orientation of human immunoglobulin G in solution: structural comparison of glycosylated and aglycosylated Fc regions using small-angle X-ray scattering. MAbs 11:453\u2013462. https:\/\/doi.org\/10.1080\/19420862.2018.1546086","journal-title":"MAbs"},{"key":"32_CR63","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.bbagen.2005.10.002","volume":"1760","author":"Y Yamaguchi","year":"2006","unstructured":"Yamaguchi Y et al (2006) Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim Biophys Acta-Gen 1760:693\u2013700. https:\/\/doi.org\/10.1016\/j.bbagen.2005.10.002","journal-title":"Biochim Biophys Acta-Gen"},{"key":"32_CR64","doi-asserted-by":"publisher","unstructured":"Yamane-Ohnuki N, Satoh M (2009) Production of therapeutic antibodies with controlled fucosylation. mAbs:230\u2013236. https:\/\/doi.org\/10.4161\/mabs.1.3.8328","DOI":"10.4161\/mabs.1.3.8328"},{"key":"32_CR65","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/1535-7163.MCT-21-0715","volume":"21","author":"F Zammarchi","year":"2022","unstructured":"Zammarchi F et al (2022) Preclinical development of ADCT-601, a novel Pyrrolobenzodiazepine dimer-based antibody\u2013drug conjugate targeting AXL-expressing cancers. Mol Cancer Ther 21:582\u2013593. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0715","journal-title":"Mol Cancer Ther"},{"key":"32_CR66","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1021\/bc400122c","volume":"24","author":"BM Zeglis","year":"2013","unstructured":"Zeglis BM et al (2013) Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry. Bioconjug Chem 24:7303\u20137310. https:\/\/doi.org\/10.1021\/bc400122c","journal-title":"Bioconjug Chem"},{"key":"32_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103114","volume":"91","author":"K Zhao","year":"2019","unstructured":"Zhao K et al (2019) One-step immobilization and purification of genetic engineering CBD fusion EndoS on cellulose for antibodies Fc-glycan remodeling. Bioorg Chem 91:103114. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103114","journal-title":"Bioorg Chem"},{"key":"32_CR68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/bc400505q","volume":"25","author":"Q Zhou","year":"2014","unstructured":"Zhou Q et al (2014) Site-specific antibody\u2212drug conjugation through glycoengineering. Bioconjug Chem 25:510\u2013520. https:\/\/doi.org\/10.1021\/bc400505q","journal-title":"Bioconjug Chem"},{"key":"32_CR69","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1039\/C2CC32412A","volume":"48","author":"K Zuberbuhler","year":"2012","unstructured":"Zuberbuhler K et al (2012) Fucose-specific conjugation of hydrazide derivatives to a vascular-targeting monoclonal antibody in IgG format. Chem Commun 48:7100\u20137102. https:\/\/doi.org\/10.1039\/C2CC32412A","journal-title":"Chem Commun"}],"container-title":["Advances in Experimental Medicine and Biology","The Molecular Immunology of Complex Carbohydrates - 4"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-04153-1_32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:20:50Z","timestamp":1774999250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-04153-1_32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032041524","9783032041531"],"references-count":69,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-04153-1_32","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}